Menu

Blog

Feb 6, 2020

Who owns the coronavirus cure? China’s move to patent Gilead’s experimental drug for the novel virus could lead to legal wrangle

Posted by in categories: biotech/medical, law

China has applied to patent a drug candidate being developed by US biotechnology firm Gilead Sciences in its search for a cure for coronavirus infection. It could raise questions on intellectual property and marketing rights.

Comments are closed.